IgA Antibodies

Immunology


Description

Deficiency of immunoglobulin A (IgA) is the commonest primary immunodeficiency disease affecting humans. A subpopulation of IgA deficient people have anti-IgA antibodies. Some of these patients may be at risk of serious or life threatening reactions to transfused blood or blood products that contain IgA. These reactions are frequently anaphylactic in nature and are often associated with anti-IgA antibodies. Notably, serious reactions in the absence of detected anti-IgA antibody have also been reported [1].


Indications

To delineate a subgroup of IgA deficient patients who may be at risk of serum sickness like reaction if given infusions of blood products containing IgA.


Sample Type

2mL Serum (Gel 5mL Yellow tube)


Reference Range

Negative


Turnaround Time

Within 2 weeks


Testing Frequency

As required


References

Eijkhout HW, van den Broek PJ, and van der Meer JW.Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy. Neth J Med. 2003. 61(6):213-217. [Ref 1]Cable R, et al. Practice guidelines for blood transfusion. 2nd Edition. 2007. American National Red Cross.


See Also

Immunoglobulins

Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

team

Clare Del-Duca BSc (Hons) Biomedical Science, MSc Pathological Science

Laboratory Manager - Immunology and Protein Reference Unit

You are enquiring about

IgA Antibodies